| Reference |
|---|
Panja S, Truica M, Yu C, Saggurthi V, Craige M, Whitehead K, et al. Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC. Nat Commun. 2024;15:352 pubmed publisher |
Daimon T, Bhattacharya A, Wang K, Haratake N, Nakashoji A, Ozawa H, et al. MUC1-C is a target of salinomycin in inducing ferroptosis of cancer stem cells. Cell Death Discov. 2024;10:9 pubmed publisher |
Vaid R, Thombare K, Méndez A, Burgos Panadero R, Djos A, Jachimowicz D, et al. METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma. Nucleic Acids Res. 2024;: pubmed publisher |
Hauck J, Moon D, Jiang X, Wang M, Zhao Y, Xu L, et al. Heat shock factor 1 directly regulates transsulfuration pathway to promote prostate cancer proliferation and survival. Commun Biol. 2024;7:9 pubmed publisher |
Yu Z, Dong X, Song M, Xu A, He Q, Li H, et al. Targeting UBR5 inhibits postsurgical breast cancer lung metastases by inducing CDC73 and p53 mediated apoptosis. Int J Cancer. 2024;154:723-737 pubmed publisher |
Wang J, Calizo A, Zhang L, Pino J, Lyu Y, Pollard K, et al. CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. Sci Adv. 2023;9:eadg8876 pubmed publisher |
Yamashita N, Withers H, Morimoto Y, Bhattacharya A, Haratake N, Daimon T, et al. MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells. iScience. 2023;26:108168 pubmed publisher |
McRee S, Bayer A, Pietruska J, Tsichlis P, Hinds P. AKT2 Loss Impairs BRAF-Mutant Melanoma Metastasis. Cancers (Basel). 2023;15: pubmed publisher |
Chen Y, Han L, Dufour C, Alfonso A, Giguere V. Canonical and nuclear mTOR specify distinct transcriptional programs in androgen-dependent prostate cancer cells. Mol Cancer Res. 2023;: pubmed publisher |
Fala M, Ros S, Sawle A, Rao J, Tsyben A, Tronci L, et al. The role of branched-chain aminotransferase 1 in driving glioblastoma cell proliferation and invasion varies with tumor subtype. Neurooncol Adv. 2023;5:vdad120 pubmed publisher |
Taylor K, Piasecka A, Kajdasz A, Brz x119 k A, Polay Espinoza M, Bourgeois C, et al. Modulatory role of RNA helicases in MBNL-dependent alternative splicing regulation. Cell Mol Life Sci. 2023;80:335 pubmed publisher |
Bhattacharya A, Fushimi A, Wang K, Yamashita N, Morimoto Y, Ishikawa S, et al. MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression. Commun Biol. 2023;6:1030 pubmed publisher |
Topchu I, Bychkov I, Gursel D, Makhov P, Boumber Y. NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma. bioRxiv. 2023;: pubmed publisher |
Tan K, Lu W, Chen F, Shi H, Ma Y, Chen Z, et al. CRISPR-Cas9 knockout screening identifies KIAA1429 as an essential gene in Ewing sarcoma. J Exp Clin Cancer Res. 2023;42:250 pubmed publisher |
Nokkeaw A, Thamjamrassri P, Chantaravisoot N, Tangkijvanich P, Ariyachet C. Long non-coding RNA H19 promotes proliferation in hepatocellular carcinoma cells via H19/miR-107/CDK6 axis. Oncol Res. 2023;31:989-1005 pubmed publisher |
Mukhopadhyay S, Huang H, Lin Z, Ranieri M, Li S, Sahu S, et al. Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy. Cancer Res. 2023;83:4095-4111 pubmed publisher |
Krishnan R, Lapierre M, Gautreau B, Nixon K, El Ghamrasni S, Patel P, et al. RNF8 ubiquitylation of XRN2 facilitates R-loop resolution and restrains genomic instability in BRCA1 mutant cells. Nucleic Acids Res. 2023;51:10484-10505 pubmed publisher |
Einig E, Jin C, Andrioletti V, Macek B, Popov N. RNAPII-dependent ATM signaling at collisions with replication forks. Nat Commun. 2023;14:5147 pubmed publisher |
Minderman M, Lantermans H, van der Zwaan C, Hoogendijk A, van den Biggelaar M, Kersten M, et al. The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll/interleukin-1 receptor (TIR) domain. Blood Cancer J. 2023;13:125 pubmed publisher |
Garc xed a V xed lchez R, A xf1 azco Guenkova A, Dietmann S, L xf3 pez J, Mor xf3 n Calvente V, D Ambrosi S, et al. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer. Mol Cancer. 2023;22:119 pubmed publisher |
Lin C, Chang T, Wang Y, Guo L, Gao Y, Bikorimana E, et al. Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer. Res Sq. 2023;: pubmed publisher |
Niederauer C, Nguyen C, Wang Henderson M, Stein J, Strauss S, Cumberworth A, et al. Dual-color DNA-PAINT single-particle tracking enables extended studies of membrane protein interactions. Nat Commun. 2023;14:4345 pubmed publisher |
Gao R, Lv S, Chen A, Huang J, Wang L, Feng Y, et al. Cancer cell employs a microenvironmental neural signal trans-activating nucleus-mitochondria coordination to acquire stemness. Signal Transduct Target Ther. 2023;8:275 pubmed publisher |
Chen Y, Dufour C, Han L, Li T, Xia H, Giguere V. Hierarchical phosphorylation of HOXB13 by mTOR dictates its activity and oncogenic function in prostate cancer. Mol Cancer Res. 2023;: pubmed publisher |
Bychkov I, Deneka A, Topchu I, Pangeni R, Lengner C, Karanicolas J, et al. Musashi-2 (MSI2) regulation of DNA damage response in lung cancer. bioRxiv. 2023;: pubmed publisher |
Shimizu S, Kondo J, Onuma K, Coppo R, Ota K, Kamada M, et al. Inhibition of the bone morphogenetic protein pathway suppresses tumor growth through downregulation of epidermal growth factor receptor in MEK/ERK-dependent colorectal cancer. Cancer Sci. 2023;: pubmed publisher |
Acharya B, Fang J, Jeffery E, Chavkin N, Genet G, Vasavada H, et al. Connexin 37 sequestering of activated-ERK in the cytoplasm promotes p27-mediated endothelial cell cycle arrest. Life Sci Alliance. 2023;6: pubmed publisher |
Sugarman A, Huynh L, Shabro A, Di Cristofano A. Anaplastic Thyroid Cancer Cells Upregulate Mitochondrial One-Carbon Metabolism To Meet Purine Demand, Eliciting A Critical Targetable Vulnerability. bioRxiv. 2023;: pubmed publisher |
Ma H, Sukonina V, Zhang W, Meng F, Subhash S, Palmgren H, et al. The transcription factor Foxp1 regulates aerobic glycolysis in adipocytes and myocytes. J Biol Chem. 2023;299:104795 pubmed publisher |
Bagheri M, Mohamed G, Ashick M, Saleem M, Ognjenovic N, Lu H, et al. Pharmacological Induction of mesenchymal-epithelial transition chemosensitizes breast cancer cells and prevents metastatic progression. bioRxiv. 2023;: pubmed publisher |
Shah A, Guo L, Morales M, Jaichander P, Chen K, Huang H, et al. TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma. Sci Adv. 2023;9:eade8184 pubmed publisher |
Wang L, Paudel B, McKnight R, Janes K. Nucleocytoplasmic transport of active HER2 causes fractional escape from the DCIS-like state. Nat Commun. 2023;14:2110 pubmed publisher |
Chen B, Das N, Talukder I, Singhal R, Castillo C, Andren A, et al. PTEN-induced kinase PINK1 supports colorectal cancer growth by regulating the labile iron pool. J Biol Chem. 2023;299:104691 pubmed publisher |
Ghosh A, Su Y, Forman M, Keyes R, Smith B, Hu X, et al. Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus Control. J Virol. 2023;97:e0016023 pubmed publisher |
Patel P, Algouneh A, Krishnan R, Reynolds J, Nixon K, Hao J, et al. Excessive transcription-replication conflicts are a vulnerability of BRCA1-mutant cancers. Nucleic Acids Res. 2023;51:4341-4362 pubmed publisher |
Xu X, Chang C, Li M, Omabe K, Le N, Chen Y, et al. DNA replication initiation factor RECQ4 possesses a role in antagonizing DNA replication initiation. Nat Commun. 2023;14:1233 pubmed publisher |
Wang J, Calizo A, Zhang L, Pino J, Lyu Y, Pollard K, et al. CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors. bioRxiv. 2023;: pubmed publisher |
Kirstein N, Dokaneheifard S, Cingaram P, Valencia M, Beckedorff F, Gomes Dos Santos H, et al. The Integrator complex regulates microRNA abundance through RISC loading. Sci Adv. 2023;9:eadf0597 pubmed publisher |
Morimoto Y, Yamashita N, Daimon T, Hirose H, Yamano S, Haratake N, et al. MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells. J Immunother Cancer. 2023;11: pubmed publisher |
Andrades E, Toll A, Deza G, Segura S, Gimeno R, Espadas G, et al. Loss of dyskerin facilitates the acquisition of metastatic traits by altering the mevalonate pathway. Life Sci Alliance. 2023;6: pubmed publisher |
Tan K, Mo J, Li M, Dong Y, Han Y, Sun X, et al. SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma. J Exp Clin Cancer Res. 2022;41:352 pubmed publisher |
Devlin A, Shukla A, Ruiz J, Barnes S, Govindan A, Hunter O, et al. The PNUTS-PP1 complex acts as an intrinsic barrier to herpesvirus KSHV gene expression and replication. Nat Commun. 2022;13:7447 pubmed publisher |
Sun Y, Hu L, Tao Z, Jarugumilli G, Erb H, Singh A, et al. Pharmacological blockade of TEAD-YAP reveals its therapeutic limitation in cancer cells. Nat Commun. 2022;13:6744 pubmed publisher |
Heijink A, Stok C, Porubský D, Manolika E, de Kanter J, Kok Y, et al. Sister chromatid exchanges induced by perturbed replication can form independently of BRCA1, BRCA2 and RAD51. Nat Commun. 2022;13:6722 pubmed publisher |
Crow J, Samuel G, Farrow E, Gibson M, Johnston J, Guest E, et al. MicroRNA Content of Ewing Sarcoma Derived Extracellular Vesicles Leads to Biomarker Potential and Identification of a Previously Undocumented EWS-FLI1 Translocation. Biomark Insights. 2022;17:11772719221132693 pubmed publisher |
Zimmerli D, Brambillasca C, Talens F, Bhin J, Linstra R, Romanens L, et al. MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling. Nat Commun. 2022;13:6579 pubmed publisher |
Zhou F, Aroua N, Liu Y, Rohde C, Cheng J, Wirth A, et al. A dynamic rRNA ribomethylome drives stemness in acute myeloid leukemia. Cancer Discov. 2022;: pubmed publisher |
Sasaya T, Kubo T, Murata K, Mizue Y, Sasaki K, Yanagawa J, et al. Cisplatin-induced HSF1-HSP90 axis enhances the expression of functional PD-L1 in oral squamous cell carcinoma. Cancer Med. 2022;: pubmed publisher |
Liao H, Gaur A, McConie H, Shekar A, Wang K, Chang J, et al. Human NOP2/NSUN1 regulates ribosome biogenesis through non-catalytic complex formation with box C/D snoRNPs. Nucleic Acids Res. 2022;50:10695-10716 pubmed publisher |
Field M, Kuznetsoff J, Zhang M, Dollar J, Durante M, Sayegh Y, et al. RB1 loss triggers dependence on ESRRG in retinoblastoma. Sci Adv. 2022;8:eabm8466 pubmed publisher |
Di Magno L, Coluccia A, Bufano M, Ripa S, La Regina G, Nalli M, et al. Discovery of novel human lactate dehydrogenase inhibitors: Structure-based virtual screening studies and biological assessment. Eur J Med Chem. 2022;240:114605 pubmed publisher |
Kerk S, Lin L, Myers A, Sutton D, Andren A, Sajjakulnukit P, et al. Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context. elife. 2022;11: pubmed publisher |
Lehmusvaara S, Haikarainen T, Saarikettu J, Martínez Nieto G, Silvennoinen O. Inhibition of RNA Binding in SND1 Increases the Levels of miR-1-3p and Sensitizes Cancer Cells to Navitoclax. Cancers (Basel). 2022;14: pubmed publisher |
Chavan S, Khuperkar D, Lonare A, Panigrahi S, Bellare J, Rapole S, et al. RanGTPase links nucleo-cytoplasmic transport to the recruitment of cargoes into small extracellular vesicles. Cell Mol Life Sci. 2022;79:392 pubmed publisher |
Liu H, Lin J, Zhou W, Moses R, Dai Z, Kossenkov A, et al. KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian Cancer. Cancer Immunol Res. 2022;:OF1-OF11 pubmed publisher |
Verma M, Loh N, Sabaratnam R, Vasan S, van Dam A, Todorcević M, et al. TCF7L2 plays a complex role in human adipose progenitor biology, which might contribute to genetic susceptibility to type 2 diabetes. Metabolism. 2022;133:155240 pubmed publisher |
Morimoto Y, Fushimi A, Yamashita N, Hagiwara M, Bhattacharya A, Cheng J, et al. Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment. Oncogene. 2022;41:3511-3523 pubmed publisher |
Yang H, Ting X, Geng Y, Xie Y, Nierenberg J, Huo Y, et al. The risk variant rs11836367 contributes to breast cancer onset and metastasis by attenuating Wnt signaling via regulating NTN4 expression. Sci Adv. 2022;8:eabn3509 pubmed publisher |
Yamashita N, Fushimi A, Morimoto Y, Bhattacharya A, Hagiwara M, Yamamoto M, et al. Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer. Cancers (Basel). 2022;14: pubmed publisher |
LI Y, Fahrmann J, Aftabizadeh M, Zhao Q, Tripathi S, Zhang C, et al. Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids. Cell Rep. 2022;39:110870 pubmed publisher |
Gulyurtlu S, Magoń M, Guest P, Papavasiliou P, Morrison K, Prescott A, et al. Condensation properties of stress granules and processing bodies are compromised in Myotonic Dystrophy Type 1. Dis Model Mech. 2022;: pubmed publisher |
Khodeer S, Klungland A, Dahl J. ALKBH5 regulates somatic cell reprogramming in a phase-specific manner. J Cell Sci. 2022;135: pubmed publisher |
Tan K, Wu W, Zhu K, Lu L, Lv Z. Identification and Characterization of a Glucometabolic Prognostic Gene Signature in Neuroblastoma based on N6-methyladenosine Eraser ALKBH5. J Cancer. 2022;13:2105-2125 pubmed publisher |
Mukha D, Fokra M, Feldman A, Sarvin B, Sarvin N, Nevo Dinur K, et al. Glycine decarboxylase maintains mitochondrial protein lipoylation to support tumor growth. Cell Metab. 2022;34:775-782.e9 pubmed publisher |
Haddock S, Alban T, Turcan S, Husic H, Rosiek E, Ma X, et al. Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells. Neoplasia. 2022;28:100790 pubmed publisher |
Fessler E, Krumwiede L, Jae L. DELE1 tracks perturbed protein import and processing in human mitochondria. Nat Commun. 2022;13:1853 pubmed publisher |
Sala M, Allain N, Moreau M, Jabouille A, Henriet E, Abou Hammoud A, et al. Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation. Oncogene. 2022;41:2571-2586 pubmed publisher |
Jiang T, Yang J, Yang H, Chen W, Ji K, Xu Y, et al. SLC35B4 Stabilizes c-MYC Protein by O-GlcNAcylation in HCC. Front Pharmacol. 2022;13:851089 pubmed publisher |
Szewczyk M, Luciani G, Vu V, Murison A, Dilworth D, Barghout S, et al. PRMT5 regulates ATF4 transcript splicing and oxidative stress response. Redox Biol. 2022;51:102282 pubmed publisher |
Sun T, Ding C, Zhang Y, Zhang Y, Lin C, Wu J, et al. MESH1 knockdown triggers proliferation arrest through TAZ repression. Cell Death Dis. 2022;13:221 pubmed publisher |
Vaidyanathan S, Salmi T, Sathiqu R, McConville M, Cox A, Brown K. YAP regulates an SGK1/mTORC1/SREBP-dependent lipogenic program to support proliferation and tissue growth. Dev Cell. 2022;57:719-731.e8 pubmed publisher |
Wang J, Yu X, Gong W, Liu X, Park K, Ma A, et al. EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis. Nat Cell Biol. 2022;24:384-399 pubmed publisher |
Blaha C, Ramakrishnan G, Jeon S, Nogueira V, Rho H, Kang S, et al. A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis. Nat Commun. 2022;13:899 pubmed publisher |
Czarnek M, Stalinska K, Sarad K, Bereta J. shRNAs targeting mouse Adam10 diminish cell response to proinflammatory stimuli independently of Adam10 silencing. Biol Open. 2022;11: pubmed publisher |
Sementino E, Kadariya Y, Cheung M, Menges C, Tan Y, Kukuyan A, et al. Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt Signaling. Mol Cancer Res. 2022;20:699-711 pubmed publisher |
Xu Y, Yu Q, Wang P, Wu Z, Zhang L, Wu S, et al. A Selective Small-Molecule c-Myc Degrader Potently Regresses Lethal c-Myc Overexpressing Tumors. Adv Sci (Weinh). 2022;9:e2104344 pubmed publisher |
Bhattacharya A, Fushimi A, Yamashita N, Hagiwara M, Morimoto Y, Rajabi H, et al. MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells. Mol Cancer Res. 2022;20:556-567 pubmed publisher |
Togami K, Chung S, Madan V, Booth C, Kenyon C, Cabal Hierro L, et al. Sex-Biased ZRSR2 Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis. Cancer Discov. 2022;12:522-541 pubmed publisher |
Bleijs M, Pleijte C, Engels S, Ringnalda F, Meyer Wentrup F, van de Wetering M, et al. EWSR1-WT1 Target Genes and Therapeutic Options Identified in a Novel DSRCT In Vitro Model. Cancers (Basel). 2021;13: pubmed publisher |
Krantz S, Kim Y, Srivastava S, Leasure J, Toth P, Marsboom G, et al. Mitophagy mediates metabolic reprogramming of induced pluripotent stem cells undergoing endothelial differentiation. J Biol Chem. 2021;297:101410 pubmed publisher |
Li J, Wu X, Schiffmann L, MacVicar T, Zhou C, Wang Z, et al. IL-17B/RB Activation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Metabolism and Growth. Cancers (Basel). 2021;13: pubmed publisher |
Yu L, Zhou D, Zhang G, Ren Z, Luo X, Liu P, et al. Co-occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence. Mol Oncol. 2021;: pubmed publisher |
Luan Z, Morimoto Y, Fushimi A, Yamashita N, Suo W, Bhattacharya A, et al. MUC1-C Dictates Neuroendocrine Lineage Specification in Pancreatic Ductal Adenocarcinomas. Carcinogenesis. 2021;: pubmed publisher |
Junqueira Alves C, Dariolli R, Haydak J, Kang S, Hannah T, Wiener R, et al. Plexin-B2 orchestrates collective stem cell dynamics via actomyosin contractility, cytoskeletal tension and adhesion. Nat Commun. 2021;12:6019 pubmed publisher |
Bhutda S, Ghosh S, Sinha A, Santra S, Hiray A, Banerjee A. Differential ubiquitination as an effective strategy employed by the Blood-Brain Barrier for prevention of bacterial transcytosis. J Bacteriol. 2021;:JB0045621 pubmed publisher |
Li J, Ohmura S, Marchetto A, Orth M, Imle R, Dallmayer M, et al. Therapeutic targeting of the PLK1-PRC1-axis triggers cell death in genomically silent childhood cancer. Nat Commun. 2021;12:5356 pubmed publisher |
Gong Z, Xue L, Wei M, Liu Z, Vlantis A, van Hasselt C, et al. The Knockdown of Nrf2 Suppressed Tumor Growth and Increased the Sensitivity to Lenvatinib in Anaplastic Thyroid Cancer. Oxid Med Cell Longev. 2021;2021:3900330 pubmed publisher |
Jaiswal A, Murakami K, Elia A, Shibahara Y, Done S, Wood S, et al. Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher |
Camacho L, Zabala Letona A, Cortázar A, Astobiza I, Dominguez Herrera A, Ercilla A, et al. Identification of Androgen Receptor Metabolic Correlome Reveals the Repression of Ceramide Kinase by Androgens. Cancers (Basel). 2021;13: pubmed publisher |
Villot R, Poirier A, Bakan I, Boulay K, Fernández E, Devillers R, et al. ZNF768 links oncogenic RAS to cellular senescence. Nat Commun. 2021;12:4841 pubmed publisher |
Kremer D, Nelson B, Lin L, Yarosz E, Halbrook C, Kerk S, et al. GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis. Nat Commun. 2021;12:4860 pubmed publisher |
Raisch J, Côté Biron A, Langlois M, Leblanc C, Rivard N. Unveiling the Roles of Low-Density Lipoprotein Receptor-Related Protein 6 in Intestinal Homeostasis, Regeneration and Oncogenesis. Cells. 2021;10: pubmed publisher |
Giuliani V, Miller M, Liu C, Hartono S, Class C, Bristow C, et al. PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma. Nat Commun. 2021;12:4626 pubmed publisher |
Kang H, Seo Y, Yun J, Song S, Han D, Cho E, et al. Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer. Cancers (Basel). 2021;13: pubmed publisher |
Richter W, Shah R, Ruthenburg A. Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia. elife. 2021;10: pubmed publisher |
Riscal R, Bull C, Mesaros C, Finan J, Carens M, Ho E, et al. Cholesterol auxotrophy as a targetable vulnerability in clear cell renal cell carcinoma. Cancer Discov. 2021;: pubmed publisher |
Kharin L, Bychkov I, Karnaukhov N, Voloshin M, Fazliyeva R, Deneka A, et al. Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression. PLoS ONE. 2021;16:e0252132 pubmed publisher |
Doubleday P, Fornelli L, Ntai I, Kelleher N. Oncogenic KRAS creates an aspartate metabolism signature in colorectal cancer cells. FEBS J. 2021;288:6683-6699 pubmed publisher |
Masurkar S, Deogharkar A, Bharambe H, Shirsat N. Downregulation of CRX, a Group 3-specific oncogenic transcription factor, inhibits TGF-β/activin signaling in medulloblastoma cells. Biochem Biophys Res Commun. 2021;568:76-82 pubmed publisher |
Zhang S, Rehling D, Jemth A, Throup A, Landazuri N, Almlöf I, et al. NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir. Cell Chem Biol. 2021;: pubmed publisher |
Hagiwara M, Fushimi A, Yamashita N, Bhattacharya A, Rajabi H, Long M, et al. MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells. Oncogene. 2021;40:4930-4940 pubmed publisher |
Devenport S, Singhal R, Radyk M, Taranto J, Kerk S, Chen B, et al. Colorectal cancer cells utilize autophagy to maintain mitochondrial metabolism for cell proliferation under nutrient stress. JCI Insight. 2021;6: pubmed publisher |
Cotter K, Gallon J, Uebersax N, Rubin P, Meyer K, Piscuoglio S, et al. Mapping of m6A and Its Regulatory Targets in Prostate Cancer Reveals a METTL3-Low Induction of Therapy Resistance. Mol Cancer Res. 2021;19:1398-1411 pubmed publisher |
Sacchetti A, Teeuwssen M, Verhagen M, Joosten R, Xu T, Stabile R, et al. Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer. elife. 2021;10: pubmed publisher |
Tao Y, Zhang J, Chen L, Liu X, Yao M, Zhang H. LncRNA CD27-AS1 promotes acute myeloid leukemia progression through the miR-224-5p/PBX3 signaling circuit. Cell Death Dis. 2021;12:510 pubmed publisher |
Xu Q, Zhang J, Telfer B, Zhang H, Ali N, Chen F, et al. The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion. Oncogene. 2021;40:3929-3941 pubmed publisher |
Kim Y, Krantz S, Jambusaria A, Toth P, Moon H, Gunarathna I, et al. Mitofusin-2 stabilizes adherens junctions and suppresses endothelial inflammation via modulation of β-catenin signaling. Nat Commun. 2021;12:2736 pubmed publisher |
Orzalli M, Prochera A, Payne L, Smith A, Garlick J, Kagan J. Virus-mediated inactivation of anti-apoptotic Bcl-2 family members promotes Gasdermin-E-dependent pyroptosis in barrier epithelial cells. Immunity. 2021;54:1447-1462.e5 pubmed publisher |
Qiu R, Wu J, Gudenas B, Northcott P, Wechsler Reya R, Lu Q. Depletion of kinesin motor KIF20A to target cell fate control suppresses medulloblastoma tumour growth. Commun Biol. 2021;4:552 pubmed publisher |
Deogharkar A, Singh S, Bharambe H, Paul R, Moiyadi A, Goel A, et al. Downregulation of ARID1B, a tumor-suppressor in the WNT subgroup medulloblastoma, activates multiple oncogenic signaling pathways. Hum Mol Genet. 2021;: pubmed publisher |
Navinés Ferrer A, Ainsua Enrich E, Serrano Candelas E, Proaño Pérez E, Muñoz Cano R, Gastaminza G, et al. MYO1F Regulates IgE and MRGPRX2-Dependent Mast Cell Exocytosis. J Immunol. 2021;206:2277-2289 pubmed publisher |
Supper E, Rudat S, Iyer V, Droop A, Wong K, Spinella J, et al. Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia. Nat Commun. 2021;12:2482 pubmed publisher |
Dai J, He Y, Jiang M, Niu M, Li B, Wu Z, et al. Reg4 regulates pancreatic regeneration following pancreatitis via modulating the Notch signaling. J Cell Physiol. 2021;: pubmed publisher |
Miyahara K, Takano N, Yamada Y, Kazama H, Tokuhisa M, Hino H, et al. BRCA1 degradation in response to mitochondrial damage in breast cancer cells. Sci Rep. 2021;11:8735 pubmed publisher |
Vallejo A, Erice O, Entrialgo Cadierno R, Feliu I, Guruceaga E, Perugorria M, et al. FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted. J Hepatol. 2021;75:363-376 pubmed publisher |
Zheng T, Ghasemi D, Okonechnikov K, Korshunov A, Sill M, Maass K, et al. Cross-species genomics reveals oncogenic dependencies in ZFTA/C11orf95 fusion-positive supratentorial ependymomas. Cancer Discov. 2021;: pubmed publisher |
Huang H, Hu J, Maryam A, Huang Q, Zhang Y, Ramakrishnan S, et al. Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling. Nat Commun. 2021;12:2242 pubmed publisher |
Corbin J, Georgescu C, Wren J, Xu C, Asch A, Ruiz Echevarría M. Seed-mediated RNA interference of androgen signaling and survival networks induces cell death in prostate cancer cells. Mol Ther Nucleic Acids. 2021;24:337-351 pubmed publisher |
Cui Y, Yang S, Wei J, Shea C, Zhong W, Wang F, et al. Autophagy of the m6A mRNA demethylase FTO is impaired by low-level arsenic exposure to promote tumorigenesis. Nat Commun. 2021;12:2183 pubmed publisher |
Niu Y, Lin Z, Wan A, Sun L, Yan S, Liang H, et al. Loss-of-function genetic screening identifies ALDOA as an essential driver for liver cancer cell growth under hypoxia. Hepatology. 2021;: pubmed publisher |
Liu Y, Xu W, Xu X, Tan Z, Xu J, Ma L, et al. Loss of BRMS2 induces cell growth inhibition and translation capacity reduction in colorectal cancer cells. Am J Cancer Res. 2021;11:930-944 pubmed |
Rashid M, Shah S, Verma T, Chaudhary N, Rauniyar S, Patel V, et al. Tumor-specific overexpression of histone gene, H3C14 in gastric cancer is mediated through EGFR-FOXC1 axis. Biochim Biophys Acta Gene Regul Mech. 2021;1864:194703 pubmed publisher |
Makhov P, Bychkov I, Faezov B, Deneka A, Kudinov A, Nicolas E, et al. Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC). Oncogenesis. 2021;10:29 pubmed publisher |
Tang D, Zhang Z, Zboril E, Wetzel M, Xu X, Zhang W, et al. Pontin Functions as A Transcriptional Co-activator for Retinoic Acid-induced HOX Gene Expression. J Mol Biol. 2021;433:166928 pubmed publisher |
Crowe M, Zavorotinskaya T, Voliva C, Shirley M, Wang Y, Ruddy D, et al. RAF-Mutant Melanomas Differentially Depend on ERK2 Over ERK1 to Support Aberrant MAPK Pathway Activation and Cell Proliferation. Mol Cancer Res. 2021;19:1063-1075 pubmed publisher |
Li J, Ullah M, Jin H, Liang Y, Lin L, Wang J, et al. ORMDL3 Functions as a Negative Regulator of Antigen-Mediated Mast Cell Activation via an ATF6-UPR-Autophagy-Dependent Pathway. Front Immunol. 2021;12:604974 pubmed publisher |
Gehmeyr J, Maghnouj A, Tjaden J, Vorgerd M, Hahn S, Matschke V, et al. Disabling VEGF-Response of Purkinje Cells by Downregulation of KDR via miRNA-204-5p. Int J Mol Sci. 2021;22: pubmed publisher |
Kennedy A, Myers K, Bowman J, Gibson C, Camarda N, Furutani E, et al. Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome. Nat Commun. 2021;12:1334 pubmed publisher |
Day E, Zhong Q, Purow B, Lazzara M. Data-driven computational modeling identifies determinants of glioblastoma response to SHP2 inhibition. Cancer Res. 2021;: pubmed publisher |
Patel P, Abraham K, Guturi K, Halaby M, Khan Z, Palomero L, et al. RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors. J Clin Invest. 2021;131: pubmed publisher |
Tameni A, Sauta E, Mularoni V, Torricelli F, Manzotti G, Inghirami G, et al. The DNA-helicase HELLS drives ALK- ALCL proliferation by the transcriptional control of a cytokinesis-related program. Cell Death Dis. 2021;12:130 pubmed publisher |
Matsui H, Shirakawa K, Konishi Y, Hirabayashi S, Sarca A, Fukuda H, et al. CAGE-seq reveals that HIV-1 latent infection does not trigger unique cellular responses in a Jurkat T cell model. J Virol. 2021;: pubmed publisher |
Yamashita N, Long M, Fushimi A, Yamamoto M, Hata T, Hagiwara M, et al. MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer. J Immunother Cancer. 2021;9: pubmed publisher |
Larrue C, Guiraud N, Mouchel P, Dubois M, Farge T, Gotanègre M, et al. Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells. Nat Commun. 2021;12:422 pubmed publisher |
Zhang Y, Gao X, Yi J, Sang X, Dai Z, Tao Z, et al. BTF3 confers oncogenic activity in prostate cancer through transcriptional upregulation of Replication Factor C. Cell Death Dis. 2021;12:12 pubmed publisher |
Alpsoy A, Utturkar S, Carter B, Dhiman A, Torregrosa Allen S, Currie M, et al. BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression. Cancer Res. 2020;: pubmed publisher |
Hagiwara M, Yasumizu Y, Yamashita N, Rajabi H, Fushimi A, Long M, et al. MUC1-C ACTIVATES THE BAF (mSWI/SNF) COMPLEX IN PROSTATE CANCER STEM CELLS. Cancer Res. 2020;: pubmed publisher |
Hsieh A, Pitarresi J, Lerner J, Donahue G, Hsiehchen D, Rustgi A, et al. Growth of pancreatic cancers with hemizygous chromosomal 17p loss of MYBBP1A can be preferentially targeted by PARP inhibitors. Sci Adv. 2020;6: pubmed publisher |
Parsels L, Engelke C, Parsels J, Flanagan S, Zhang Q, Tanska D, et al. Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination-Proficient Pancreatic Cancer. Mol Cancer Ther. 2021;20:263-273 pubmed publisher |
Wu B, Gan Y, Xu Y, Wu Z, Xu G, Wang P, et al. Identification of the novel Np17 oncogene in human leukemia. Aging (Albany NY). 2020;12:23647-23667 pubmed publisher |
Sun H, Zhu A, Gao Y, Terajima H, Fei Q, Liu S, et al. Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases m6A Methylation. Mol Cell. 2020;80:633-647.e7 pubmed publisher |
Sviderskiy V, Blumenberg L, Gorodetsky E, Karakousi T, Hirsh N, Alvarez S, et al. Hyperactive CDK2 Activity in Basal-like Breast Cancer Imposes a Genome Integrity Liability that Can Be Exploited by Targeting DNA Polymerase ε. Mol Cell. 2020;80:682-698.e7 pubmed publisher |
Baraibar I, Roman M, Rodriguez Remirez M, Lopez I, Vilalta A, Guruceaga E, et al. Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8+ T Cells. Cancers (Basel). 2020;12: pubmed publisher |
Saliakoura M, Rossi Sebastiano M, Pozzato C, Heidel F, Schnöder T, Savic Prince S, et al. PLCγ1 suppression promotes the adaptation of KRAS-mutant lung adenocarcinomas to hypoxia. Nat Cell Biol. 2020;22:1382-1395 pubmed publisher |
Kuznetsoff J, Owens D, Lopez A, Rodriguez D, Chee N, Kurtenbach S, et al. Dual Screen for Efficacy and Toxicity Identifies HDAC Inhibitor with Distinctive Activity Spectrum for BAP1-Mutant Uveal Melanoma. Mol Cancer Res. 2021;19:215-222 pubmed publisher |
Kok Y, Guerrero Llobet S, Schoonen P, Everts M, Bhattacharya A, Fehrmann R, et al. Overexpression of Cyclin E1 or Cdc25A leads to replication stress, mitotic aberrancies, and increased sensitivity to replication checkpoint inhibitors. Oncogenesis. 2020;9:88 pubmed publisher |
Ros S, Wright A, D Santos P, Hu D, Hesketh R, Lubling Y, et al. Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer. Cancer Cell. 2020;38:516-533.e9 pubmed publisher |
Kim K, Kim Y, Rivard C, Kim D, Park K. FGFR1 Is Critical for RBL2 Loss-Driven Tumor Development and Requires PLCG1 Activation for Continued Growth of Small Cell Lung Cancer. Cancer Res. 2020;80:5051-5062 pubmed publisher |
Shahrouzi P, Astobiza I, Cortázar A, Torrano V, Macchia A, Flores J, et al. Genomic and Functional Regulation of TRIB1 Contributes to Prostate Cancer Pathogenesis. Cancers (Basel). 2020;12: pubmed publisher |
Park S, Jo S, Kim J, Kim S, Ha J, Hwang J, et al. Combination Treatment with GSK126 and Pomalidomide Induces B-Cell Differentiation in EZH2 Gain-of-Function Mutant Diffuse Large B-Cell Lymphoma. Cancers (Basel). 2020;12: pubmed publisher |
Wang Y, Chen Y, Bao L, Zhang B, Wang J, Kumar A, et al. CHD4 promotes breast cancer progression as a coactivator of hypoxia-inducible factors. Cancer Res. 2020;: pubmed publisher |
Wang Z, Qin J, Zhao J, Li J, Li D, Popp M, et al. Inflammatory IFIT3 renders chemotherapy resistance by regulating post-translational modification of VDAC2 in pancreatic cancer. Theranostics. 2020;10:7178-7192 pubmed publisher |
Zhang X, Fan X, Li F, Qiu J, Zhang Y. Effects of PYRIN-containing Apaf1-like protein 1 on isoflurane-induced postoperative cognitive dysfunction in aged rats. Mol Med Rep. 2020;22:1391-1399 pubmed publisher |
Paul R, Bharambe H, Shirsat N. Autophagy inhibition impairs the invasion potential of medulloblastoma cells. Mol Biol Rep. 2020;: pubmed publisher |
Koundouros N, Karali E, Tripp A, Valle A, Inglese P, Perry N, et al. Metabolic Fingerprinting Links Oncogenic PIK3CA with Enhanced Arachidonic Acid-Derived Eicosanoids. Cell. 2020;181:1596-1611.e27 pubmed publisher |
Yang J, Kim N, Yun J, Cho E, Cha Y, Cho S, et al. Snail augments fatty acid oxidation by suppression of mitochondrial ACC2 during cancer progression. Life Sci Alliance. 2020;3: pubmed publisher |
Li W, Zhang N, Jin C, Long M, Rajabi H, Yasumizu Y, et al. MUC1-C drives stemness in progression of colitis to colorectal cancer. JCI Insight. 2020;5: pubmed publisher |
Yang L, Liu X, Song L, Su G, Di A, Bai C, et al. Melatonin restores the pluripotency of long-term-cultured embryonic stem cells through melatonin receptor-dependent m6A RNA regulation. J Pineal Res. 2020;:e12669 pubmed publisher |
Bong S, Bae S, Song B, Gwak H, Yang S, Kim S, et al. Regulation of mRNA export through API5 and nuclear FGF2 interaction. Nucleic Acids Res. 2020;48:6340-6352 pubmed publisher |
Pan J, Silva T, Gull N, Yang Q, Plummer J, Chen S, et al. Lineage-Specific Epigenomic and Genomic Activation of Oncogene HNF4A Promotes Gastrointestinal Adenocarcinomas. Cancer Res. 2020;80:2722-2736 pubmed publisher |
Gilbert Girard S, Gravel A, Collin V, Wight D, Kaufer B, Lazzerini Denchi E, et al. Role for the shelterin protein TRF2 in human herpesvirus 6A/B chromosomal integration. PLoS Pathog. 2020;16:e1008496 pubmed publisher |
Xia L, Bouamar H, Gu X, Zeballos C, Qin T, Wang B, et al. Gli2 mediates the development of castration‑resistant prostate cancer. Int J Oncol. 2020;57:100-112 pubmed publisher |
Sharma S, Munger K. KDM6A-Mediated Expression of the Long Noncoding RNA DINO Causes TP53 Tumor Suppressor Stabilization in Human Papillomavirus 16 E7-Expressing Cells. J Virol. 2020;94: pubmed publisher |
Qiu Z, Lin A, Jiang S, Elkashef S, Myers J, Srikantan S, et al. MYC Regulation of D2HGDH and L2HGDH Influences the Epigenome and Epitranscriptome. Cell Chem Biol. 2020;27:538-550.e7 pubmed publisher |
Teraoka S, Muguruma M, Takano N, Miyahara K, Kawate T, Kaise H, et al. Association of BRCA Mutations and BRCAness Status With Anticancer Drug Sensitivities in Triple-Negative Breast Cancer Cell Lines. J Surg Res. 2020;250:200-208 pubmed publisher |
Zhao B, Liu P, Fukumoto T, Nacarelli T, Fatkhutdinov N, Wu S, et al. Topoisomerase 1 cleavage complex enables pattern recognition and inflammation during senescence. Nat Commun. 2020;11:908 pubmed publisher |
Wang H, Zhang S, Song L, Qu M, Zou Z. Synergistic lethality between PARP-trapping and alantolactone-induced oxidative DNA damage in homologous recombination-proficient cancer cells. Oncogene. 2020;39:2905-2920 pubmed publisher |
Yu L, Kim J, Jiang L, Feng B, Ying Y, Ji K, et al. MTR4 drives liver tumorigenesis by promoting cancer metabolic switch through alternative splicing. Nat Commun. 2020;11:708 pubmed publisher |
Ishihara E, Nagaoka Y, Okuno T, Kofuji S, Ishigami Yuasa M, Kagechika H, et al. Prostaglandin E2 and its receptor EP2 trigger signaling that contributes to YAP-mediated cell competition. Genes Cells. 2020;25:197-214 pubmed publisher |
De Troyer L, Zhao P, Pastor T, Baietti M, Barra J, Vendramin R, et al. Stress-induced lncRNA LASTR fosters cancer cell fitness by regulating the activity of the U4/U6 recycling factor SART3. Nucleic Acids Res. 2020;48:2502-2517 pubmed publisher |
Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long M, et al. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Nat Commun. 2020;11:338 pubmed publisher |
Hanniford D, Ulloa Morales A, Karz A, Berzoti Coelho M, Moubarak R, Sánchez Sendra B, et al. Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis. Cancer Cell. 2020;37:55-70.e15 pubmed publisher |
Ware T, Franks C, Granade M, Zhang M, Kim K, Park K, et al. Reprogramming fatty acyl specificity of lipid kinases via C1 domain engineering. Nat Chem Biol. 2020;16:170-178 pubmed publisher |
Liu Q, Borcherding N, Shao P, Maina P, Zhang W, Qi H. Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance. EBioMedicine. 2020;51:102612 pubmed publisher |
Nacarelli T, Fukumoto T, Zundell J, Fatkhutdinov N, Jean S, Cadungog M, et al. NAMPT inhibition suppresses cancer stem-like cells associated with therapy-induced senescence in ovarian cancer. Cancer Res. 2019;: pubmed publisher |
Hoj J, Mayro B, Pendergast A. A TAZ-AXL-ABL2 Feed-Forward Signaling Axis Promotes Lung Adenocarcinoma Brain Metastasis. Cell Rep. 2019;29:3421-3434.e8 pubmed publisher |
Werner A, Pieh D, Echchannaoui H, Rupp J, Rajalingam K, Theobald M, et al. Cationic Amino Acid Transporter-1-Mediated Arginine Uptake Is Essential for Chronic Lymphocytic Leukemia Cell Proliferation and Viability. Front Oncol. 2019;9:1268 pubmed publisher |
Satoh T, Mellett M, Meier Schiesser B, Fenini G, Otsuka A, Beer H, et al. IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes. J Clin Invest. 2019;: pubmed publisher |
Huang Y, Mouttet B, Warnatz H, Risch T, Rietmann F, Frommelt F, et al. The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability. Cancer Cell. 2019;36:630-644.e9 pubmed publisher |
Ma G, Gezer D, Herrmann O, Feldberg K, Schemionek M, Jawhar M, et al. LCP1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophilia. Mol Carcinog. 2020;59:87-103 pubmed publisher |
Valcarcel Jimenez L, Macchia A, Crosas Molist E, Schaub Clerigué A, Camacho L, Martin Martin N, et al. PGC1α Suppresses Prostate Cancer Cell Invasion through ERRα Transcriptional Control. Cancer Res. 2019;79:6153-6165 pubmed publisher |
Arreal L, Piva M, Fernandez S, Revandkar A, Schaub Clerigué A, Villanueva J, et al. Targeting PML in triple negative breast cancer elicits growth suppression and senescence. Cell Death Differ. 2019;: pubmed publisher |
Lim C, Davis O, Shin H, Zhang J, Berdan C, Jiang X, et al. ER-lysosome contacts enable cholesterol sensing by mTORC1 and drive aberrant growth signalling in Niemann-Pick type C. Nat Cell Biol. 2019;21:1206-1218 pubmed publisher |
Hata T, Rajabi H, Takahashi H, Yasumizu Y, Li W, Jin C, et al. MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells. Cancer Res. 2019;79:5711-5722 pubmed publisher |
Kim Y, Kim H, Kim H, Gawk H, Bae S, Sim H, et al. FAK-Copy-Gain Is a Predictive Marker for Sensitivity to FAK Inhibition in Breast Cancer. Cancers (Basel). 2019;11: pubmed publisher |
Heijink A, Everts M, Honeywell M, Richards R, Kok Y, de Vries E, et al. Modeling of Cisplatin-Induced Signaling Dynamics in Triple-Negative Breast Cancer Cells Reveals Mediators of Sensitivity. Cell Rep. 2019;28:2345-2357.e5 pubmed publisher |
Hsieh M, Choe J, Gadhvi J, Kim Y, Arguez M, Palmer M, et al. p63 and SOX2 Dictate Glucose Reliance and Metabolic Vulnerabilities in Squamous Cell Carcinomas. Cell Rep. 2019;28:1860-1878.e9 pubmed publisher |
Nishimura N, Radwan M, Amano M, Endo S, Fujii E, Hayashi H, et al. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells. Cancer Sci. 2019;110:3275-3287 pubmed publisher |
Kallunki T, Barisic M, Jaattela M, Liu B. How to Choose the Right Inducible Gene Expression System for Mammalian Studies?. Cells. 2019;8: pubmed publisher |
Field M, Kuznetsov J, Bussies P, Cai L, Alawa K, Decatur C, et al. BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas. Clin Cancer Res. 2019;25:5663-5673 pubmed publisher |
Sastre Perona A, Hoang Phou S, Leitner M, Okuniewska M, Meehan S, Schober M. De Novo PITX1 Expression Controls Bi-Stable Transcriptional Circuits to Govern Self-Renewal and Differentiation in Squamous Cell Carcinoma. Cell Stem Cell. 2019;24:390-404.e8 pubmed publisher |
Kim J, Yu L, Chen W, Xu Y, Wu M, Todorova D, et al. Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation. Cancer Cell. 2019;35:191-203.e8 pubmed publisher |
Paschos K, Bazot Q, Lees J, Farrell P, Allday M. Requirement for PRC1 subunit BMI1 in host gene activation by Epstein-Barr virus protein EBNA3C. Nucleic Acids Res. 2019;47:2807-2821 pubmed publisher |
Heijink A, Talens F, Jae L, van Gijn S, Fehrmann R, Brummelkamp T, et al. BRCA2 deficiency instigates cGAS-mediated inflammatory signaling and confers sensitivity to tumor necrosis factor-alpha-mediated cytotoxicity. Nat Commun. 2019;10:100 pubmed publisher |
Sun Y, Bandi M, Lofton T, Smith M, Bristow C, Carugo A, et al. Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation. Cell Rep. 2019;26:469-482.e5 pubmed publisher |
Lee J, Kim S, Song J, Lee Y, Ko H. Anti-Human Rhinovirus 1B Activity of Dexamethasone viaGCR-Dependent Autophagy Activation. Osong Public Health Res Perspect. 2018;9:334-339 pubmed publisher |
Oladimeji P, Wright W, Wu J, Chen T. RNA interference screen identifies NAA10 as a regulator of PXR transcription. Biochem Pharmacol. 2019;160:92-109 pubmed publisher |
Roman M, Lopez I, Guruceaga E, Baraibar I, Ecay M, Collantes M, et al. Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network. Cancer Res. 2019;79:625-638 pubmed publisher |
Wehde B, Rädler P, Shrestha H, Johnson S, Triplett A, Wagner K. Janus Kinase 1 Plays a Critical Role in Mammary Cancer Progression. Cell Rep. 2018;25:2192-2207.e5 pubmed publisher |
Kubala M, Punj V, Placencio Hickok V, Fang H, Fernandez G, Sposto R, et al. Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer. Cell Rep. 2018;25:2177-2191.e7 pubmed publisher |
Villar Prados A, Wu S, Court K, Ma S, LaFargue C, Chowdhury M, et al. Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4. Mol Cancer Ther. 2019;18:421-436 pubmed publisher |
Witwicki R, Ekram M, Qiu X, Janiszewska M, Shu S, Kwon M, et al. TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer. Cell Rep. 2018;25:1255-1267.e5 pubmed publisher |
Marcus A, Mao A, Lensink Vasan M, Wang L, Vance R, Raulet D. Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response. Immunity. 2018;49:754-763.e4 pubmed publisher |
Tu W, Shiah Y, Lourenco C, Mullen P, Dingar D, Redel C, et al. MYC Interacts with the G9a Histone Methyltransferase to Drive Transcriptional Repression and Tumorigenesis. Cancer Cell. 2018;34:579-595.e8 pubmed publisher |
Bertero T, Oldham W, Grasset E, Bourget I, Boulter E, Pisano S, et al. Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy. Cell Metab. 2019;29:124-140.e10 pubmed publisher |
Lin C, Lo M, Moody R, Jiang H, Harouaka R, Stevers N, et al. Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer. Cancer Lett. 2018;438:165-173 pubmed publisher |
Ackerman D, Tumanov S, Qiu B, Michalopoulou E, Spata M, Azzam A, et al. Triglycerides Promote Lipid Homeostasis during Hypoxic Stress by Balancing Fatty Acid Saturation. Cell Rep. 2018;24:2596-2605.e5 pubmed publisher |
Song B, Kim D, Shin J, Bae S, Kim H, Won B, et al. OCT4 directly regulates stemness and extracellular matrix-related genes in human germ cell tumours. Biochem Biophys Res Commun. 2018;503:1980-1986 pubmed publisher |
Brzek A, Cichocka M, Dolata J, Juzwa W, Schumperli D, Raczynska K. Positive cofactor 4 (PC4) contributes to the regulation of replication-dependent canonical histone gene expression. BMC Mol Biol. 2018;19:9 pubmed publisher |
Yang D, Cheng D, Tu Q, Yang H, Sun B, Yan L, et al. HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53. Theranostics. 2018;8:3517-3529 pubmed publisher |
Barbieri E, Trizzino M, Welsh S, Owens T, Calabretta B, Carroll M, et al. Targeted Enhancer Activation by a Subunit of the Integrator Complex. Mol Cell. 2018;71:103-116.e7 pubmed publisher |
Tsvetkov P, Adler J, Myers N, Biran A, Reuven N, Shaul Y. Oncogenic addiction to high 26S proteasome level. Cell Death Dis. 2018;9:773 pubmed publisher |
Zhu H, Xia L, Shen Q, Zhao M, Gu X, Bouamar H, et al. Differential effects of GLI2 and GLI3 in regulating cervical cancer malignancy in vitro and in vivo. Lab Invest. 2018;98:1384-1396 pubmed publisher |
Wu C, Jiang X, Wang X, Liu X, Li X, Yang B, et al. Human Cytomegalovirus Immediate Early 1 Protein Causes Loss of SOX2 from Neural Progenitor Cells by Trapping Unphosphorylated STAT3 in the Nucleus. J Virol. 2018;92: pubmed publisher |
Chen H, Yu H, Yang M, Tarn W. DDX3 Activates CBC-eIF3-Mediated Translation of uORF-Containing Oncogenic mRNAs to Promote Metastasis in HNSCC. Cancer Res. 2018;78:4512-4523 pubmed publisher |
Lee Y, Kim N, Cho E, Yang J, Cha Y, Kang H, et al. Dishevelled has a YAP nuclear export function in a tumor suppressor context-dependent manner. Nat Commun. 2018;9:2301 pubmed publisher |
Sanchez D, Steger D, Skuli N, Bansal A, Simon M. PPARγ is dispensable for clear cell renal cell carcinoma progression. Mol Metab. 2018;14:139-149 pubmed publisher |
Hong H, An O, Chan T, Ng V, Kwok H, Lin J, et al. Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer. Nucleic Acids Res. 2018;46:7953-7969 pubmed publisher |
Sakamoto K, Katayama R, Asaka R, Sakata S, Baba S, Nakasone H, et al. Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response. Leukemia. 2018;32:2590-2603 pubmed publisher |
Ng S, Yoshida N, Christie A, Ghandi M, Dharia N, Dempster J, et al. Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models. Nat Commun. 2018;9:2024 pubmed publisher |
Hiraki M, Maeda T, Mehrotra N, Jin C, Alam M, Bouillez A, et al. Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer. Signal Transduct Target Ther. 2018;3:13 pubmed publisher |
Amaral P, Leonardi T, Han N, Viré E, Gascoigne D, Arias Carrasco R, et al. Genomic positional conservation identifies topological anchor point RNAs linked to developmental loci. Genome Biol. 2018;19:32 pubmed publisher |
Deel M, Slemmons K, Hinson A, Genadry K, Burgess B, Crose L, et al. The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis. Clin Cancer Res. 2018;24:2616-2630 pubmed publisher |
Caro Maldonado A, Camacho L, Zabala Letona A, Torrano V, Fern ndez Ruiz S, Zamacola Bascaran K, et al. Low-dose statin treatment increases prostate cancer aggressiveness. Oncotarget. 2018;9:1494-1504 pubmed publisher |
Kim S, Song J, Ahn J, Lee G, Ahn H, Yoon S, et al. Antiviral and anti-inflammatory activity of budesonide against human rhinovirus infection mediated via autophagy activation. Antiviral Res. 2018;151:87-96 pubmed publisher |
Bozal Basterra L, Martín Ruiz I, Pirone L, Liang Y, Sigurðsson J, Gonzalez Santamarta M, et al. Truncated SALL1 Impedes Primary Cilia Function in Townes-Brocks Syndrome. Am J Hum Genet. 2018;102:249-265 pubmed publisher |
Jutten B, Keulers T, Peeters H, Schaaf M, Savelkouls K, Compter I, et al. EGFRvIII expression triggers a metabolic dependency and therapeutic vulnerability sensitive to autophagy inhibition. Autophagy. 2018;14:283-295 pubmed publisher |
Vl kov K, Vachtenheim J, R da J, Hor k P, Ondru ov L. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells. J Cell Mol Med. 2018;22:2240-2251 pubmed publisher |
Hanna J, Garcia M, Lardennois A, Leavey P, Maglic D, Fagnan A, et al. PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma. Oncogene. 2018;37:1991-2007 pubmed publisher |
Li Y, Bakke J, Finkelstein D, Zeng H, Wu J, Chen T. HNRNPH1 is required for rhabdomyosarcoma cell growth and survival. Oncogenesis. 2018;7:9 pubmed publisher |
Gwinn D, Lee A, Briones Martin del Campo M, Conn C, Simpson D, Scott A, et al. Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase. Cancer Cell. 2018;33:91-107.e6 pubmed publisher |
Maeda T, Hiraki M, Jin C, Rajabi H, Tagde A, Alam M, et al. MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer. Cancer Res. 2018;78:205-215 pubmed publisher |
He P, Yang J, Yang V, Bialkowska A. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice. Gastroenterology. 2018;154:1494-1508.e13 pubmed publisher |
Bajikar S, Wang C, Borten M, Pereira E, Atkins K, Janes K. Tumor-Suppressor Inactivation of GDF11 Occurs by Precursor Sequestration in Triple-Negative Breast Cancer. Dev Cell. 2017;43:418-435.e13 pubmed publisher |
Shukla S, Cyrta J, Murphy D, Walczak E, Ran L, Agrawal P, et al. Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance. Cancer Cell. 2017;32:792-806.e7 pubmed publisher |
Mu Y, Yan X, Li D, Zhao D, Wang L, Wang X, et al. NUPR1 maintains autolysosomal efflux by activating SNAP25 transcription in cancer cells. Autophagy. 2018;14:654-670 pubmed publisher |
Alwosaibai K, Abedini A, Al Hujaily E, Tang Y, Garson K, Collins O, et al. PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state. Oncotarget. 2017;8:76881-76897 pubmed publisher |
Orlacchio A, Ranieri M, Brave M, Arciuch V, Forde T, De Martino D, et al. SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and Maintenance. Cancer Res. 2017;77:6914-6926 pubmed publisher |
Tagde A, Markert T, Rajabi H, Hiraki M, Alam M, Bouillez A, et al. Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma. Oncotarget. 2017;8:69237-69249 pubmed publisher |
Cheng J, Park D, Berrios C, White E, Arora R, Yoon R, et al. Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis. PLoS Pathog. 2017;13:e1006668 pubmed publisher |
Huang H, Seo H, Zhang T, Wang Y, Jiang B, Li Q, et al. MELK is not necessary for the proliferation of basal-like breast cancer cells. elife. 2017;6: pubmed publisher |
Slemmons K, Crose L, Riedel S, Sushnitha M, Belyea B, Linardic C. A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma. Mol Cancer Res. 2017;15:1777-1791 pubmed publisher |
Hospital M, Jacquel A, Mazed F, Saland E, Larrue C, Mondesir J, et al. RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia. Leukemia. 2018;32:597-605 pubmed publisher |
Kranz P, Neumann F, Wolf A, Classen F, Pompsch M, Ocklenburg T, et al. PDI is an essential redox-sensitive activator of PERK during the unfolded protein response (UPR). Cell Death Dis. 2017;8:e2986 pubmed publisher |
Rajabi H, Hiraki M, Tagde A, Alam M, Bouillez A, Christensen C, et al. MUC1-C activates EZH2 expression and function in human cancer cells. Sci Rep. 2017;7:7481 pubmed publisher |
Maina P, Shao P, Jia X, Liu Q, Umesalma S, Marin M, et al. Histone demethylase PHF8 regulates hypoxia signaling through HIF1? and H3K4me3. Biochim Biophys Acta Gene Regul Mech. 2017;1860:1002-1012 pubmed publisher |
Yang D, Sun B, Zhang X, Cheng D, Yu X, Yan L, et al. Huwe1 Sustains Normal Ovarian Epithelial Cell Transformation and Tumor Growth through the Histone H1.3-H19 Cascade. Cancer Res. 2017;77:4773-4784 pubmed publisher |
Zabala Letona A, Arruabarrena Aristorena A, Martin Martin N, Fernandez Ruiz S, Sutherland J, Clasquin M, et al. mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer. Nature. 2017;547:109-113 pubmed publisher |
Zarei M, Lal S, Parker S, Nevler A, Vaziri Gohar A, Dukleska K, et al. Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer Cells. Cancer Res. 2017;77:4460-4471 pubmed publisher |
Ashwini A, Naganur S, Smitha B, Sheshadri P, Prasanna J, Kumar A. Cyclosporine A-Mediated IL-6 Expression Promotes Neural Induction in Pluripotent Stem Cells. Mol Neurobiol. 2018;55:4267-4279 pubmed publisher |
Raices M, Bukata L, Sakuma S, Borlido J, Hernandez L, Hart D, et al. Nuclear Pores Regulate Muscle Development and Maintenance by Assembling a Localized Mef2C Complex. Dev Cell. 2017;41:540-554.e7 pubmed publisher |
Karathedath S, Rajamani B, Musheer Aalam S, Abraham A, Varatharajan S, Krishnamurthy P, et al. Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2. PLoS ONE. 2017;12:e0177227 pubmed publisher |
Choi E, Jung B, Lee S, Yoo H, Shin E, Ko H, et al. A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer. Oncogene. 2017;36:5285-5295 pubmed publisher |
Lampada A, O Prey J, Szabadkai G, Ryan K, Hochhauser D, Salomoni P. mTORC1-independent autophagy regulates receptor tyrosine kinase phosphorylation in colorectal cancer cells via an mTORC2-mediated mechanism. Cell Death Differ. 2017;24:1045-1062 pubmed publisher |
Ku A, Shaver T, Rao A, Howard J, Rodriguez C, Miao Q, et al. TCF7L1 promotes skin tumorigenesis independently of β-catenin through induction of LCN2. elife. 2017;6: pubmed publisher |
Ahn S, Kim N, Lee K, Cha Y, Yang J, Cha S, et al. Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction. Oncotarget. 2017;8:31842-31855 pubmed publisher |
Poulain L, Sujobert P, Zylbersztejn F, Barreau S, Stuani L, Lambert M, et al. High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells. Leukemia. 2017;31:2326-2335 pubmed publisher |
Frank S, Schulz V, Miranti C. A streamlined method for the design and cloning of shRNAs into an optimized Dox-inducible lentiviral vector. BMC Biotechnol. 2017;17:24 pubmed publisher |
Kohler R, Kettelhack H, Knipprath Mészaros A, Fedier A, Schoetzau A, Jacob F, et al. MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells. Gynecol Oncol. 2017;145:159-166 pubmed publisher |
Shah M, Cardenas R, Wang B, Persson J, Mongan N, Grabowska A, et al. HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells. Mol Cancer. 2017;16:38 pubmed publisher |
Zaini M, Muller C, Ackermann T, Reinshagen J, Kortman G, Pless O, et al. A screening strategy for the discovery of drugs that reduce C/EBPβ-LIP translation with potential calorie restriction mimetic properties. Sci Rep. 2017;7:42603 pubmed publisher |
Paolella B, Gibson W, Urbanski L, Alberta J, Zack T, Bandopadhayay P, et al. Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability. elife. 2017;6: pubmed publisher |
Kim N, Cha Y, Lee J, Lee S, Yang J, Yun J, et al. Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress. Nat Commun. 2017;8:14374 pubmed publisher |
Gayle S, Landrette S, Beeharry N, Conrad C, Hernandez M, Beckett P, et al. Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma. Blood. 2017;129:1768-1778 pubmed publisher |
Paschos K, Bazot Q, Ho G, Parker G, Lees J, Barton G, et al. Core binding factor (CBF) is required for Epstein-Barr virus EBNA3 proteins to regulate target gene expression. Nucleic Acids Res. 2017;45:2368-2383 pubmed publisher |
Hiraki M, Maeda T, Bouillez A, Alam M, Tagde A, Hinohara K, et al. MUC1-C activates BMI1 in human cancer cells. Oncogene. 2017;36:2791-2801 pubmed publisher |
Yu L, Liang Y, Cao X, Wang X, Gao H, Lin S, et al. Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer. Oncogene. 2017;36:2910-2918 pubmed publisher |
Yang W, Nagasawa K, Münch C, Xu Y, Satterstrom K, Jeong S, et al. Mitochondrial Sirtuin Network Reveals Dynamic SIRT3-Dependent Deacetylation in Response to Membrane Depolarization. Cell. 2016;167:985-1000.e21 pubmed publisher |
Chromá K, Mistrik M, Moudry P, Gursky J, Liptay M, Strauss R, et al. Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress. Oncogene. 2017;36:2405-2422 pubmed publisher |
Maina P, Shao P, Liu Q, Fazli L, Tyler S, Nasir M, et al. c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer. Oncotarget. 2016;7:75585-75602 pubmed publisher |
Alam M, Bouillez A, Tagde A, Ahmad R, Rajabi H, Maeda T, et al. MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway. Mol Cancer Res. 2016;14:1266-1276 pubmed |
Martin Martin N, Piva M, Urosevic J, Aldaz P, Sutherland J, Fernandez Ruiz S, et al. Stratification and therapeutic potential of PML in metastatic breast cancer. Nat Commun. 2016;7:12595 pubmed publisher |
Lee Y, Kaduwal S, Lee K, Park J, Jeong W, Choi K. Sur8 mediates tumorigenesis and metastasis in colorectal cancer. Exp Mol Med. 2016;48:e249 pubmed publisher |
Harwardt T, Lukas S, Zenger M, Reitberger T, Danzer D, Übner T, et al. Human Cytomegalovirus Immediate-Early 1 Protein Rewires Upstream STAT3 to Downstream STAT1 Signaling Switching an IL6-Type to an IFNγ-Like Response. PLoS Pathog. 2016;12:e1005748 pubmed publisher |
Murphy M, Chatterjee S, Jain S, KATARI M, DasGupta R. TCF7L1 Modulates Colorectal Cancer Growth by Inhibiting Expression of the Tumor-Suppressor Gene EPHB3. Sci Rep. 2016;6:28299 pubmed publisher |
Hiraki M, Suzuki Y, Alam M, Hinohara K, Hasegawa M, Jin C, et al. MUC1-C Stabilizes MCL-1 in the Oxidative Stress Response of Triple-Negative Breast Cancer Cells to BCL-2 Inhibitors. Sci Rep. 2016;6:26643 pubmed publisher |
Wang Y, Li Y, Guo C, Lu Q, Wang W, Jia Z, et al. ISL1 and JMJD3 synergistically control cardiac differentiation of embryonic stem cells. Nucleic Acids Res. 2016;44:6741-55 pubmed publisher |
Sun S, Cheng S, Zhu Y, Zhang P, Liu N, Xu T, et al. Identification of PRKDC (Protein Kinase, DNA-Activated, Catalytic Polypeptide) as an essential gene for colorectal cancer (CRCs) cells. Gene. 2016;584:90-6 pubmed publisher |
Srinivas K, Viji R, Dan V, Sajitha I, Prakash R, Rahul P, et al. DEPTOR promotes survival of cervical squamous cell carcinoma cells and its silencing induces apoptosis through downregulating PI3K/AKT and by up-regulating p38 MAP kinase. Oncotarget. 2016;7:24154-71 pubmed publisher |
Mungamuri S, Qiao R, Yao S, Manfredi J, Gu W, Aaronson S. USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation. Cell Rep. 2016;14:2528-37 pubmed publisher |
Pattabiraman D, Bierie B, Kober K, Thiru P, Krall J, Zill C, et al. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. Science. 2016;351:aad3680 pubmed publisher |
Hasegawa M, Takahashi H, Rajabi H, Alam M, Suzuki Y, Yin L, et al. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells. Oncotarget. 2016;7:11756-69 pubmed publisher |
Schlienger S, Campbell S, Pasquin S, Gaboury L, Claing A. ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer. Oncotarget. 2016;7:15811-27 pubmed publisher |
Luo W, Chen I, Chen Y, Alkam D, Wang Y, Semenza G. PRDX2 and PRDX4 are negative regulators of hypoxia-inducible factors under conditions of prolonged hypoxia. Oncotarget. 2016;7:6379-97 pubmed publisher |
El Karoui K, Viau A, Dellis O, Bagattin A, Nguyen C, BARON W, et al. Endoplasmic reticulum stress drives proteinuria-induced kidney lesions via Lipocalin 2. Nat Commun. 2016;7:10330 pubmed publisher |
Jutz S, Leitner J, Schmetterer K, Doel Perez I, Majdic O, Grabmeier Pfistershammer K, et al. Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1. J Immunol Methods. 2016;430:10-20 pubmed publisher |
Hsiao C, Lampe M, Nillasithanukroh S, Han W, Lian X, Palecek S. Human pluripotent stem cell culture density modulates YAP signaling. Biotechnol J. 2016;11:662-75 pubmed publisher |
Jimbo M, Blanco F, Huang Y, Telonis A, Screnci B, Cosma G, et al. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells. Oncotarget. 2015;6:27312-31 pubmed publisher |
Laperle A, Hsiao C, Lampe M, Mortier J, Saha K, Palecek S, et al. α-5 Laminin Synthesized by Human Pluripotent Stem Cells Promotes Self-Renewal. Stem Cell Reports. 2015;5:195-206 pubmed publisher |
Jacque N, Ronchetti A, Larrue C, Meunier G, Birsen R, Willems L, et al. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition. Blood. 2015;126:1346-56 pubmed publisher |
Zidek L, Ackermann T, Hartleben G, Eichwald S, Kortman G, Kiehntopf M, et al. Deficiency in mTORC1-controlled C/EBPβ-mRNA translation improves metabolic health in mice. EMBO Rep. 2015;16:1022-36 pubmed publisher |
D Osualdo A, Anania V, Yu K, Lill J, Kaufman R, Matsuzawa S, et al. Transcription Factor ATF4 Induces NLRP1 Inflammasome Expression during Endoplasmic Reticulum Stress. PLoS ONE. 2015;10:e0130635 pubmed publisher |
Kephart J, Tiller R, Crose L, Slemmons K, Chen P, Hinson A, et al. Secreted Frizzled-Related Protein 3 (SFRP3) Is Required for Tumorigenesis of PAX3-FOXO1-Positive Alveolar Rhabdomyosarcoma. Clin Cancer Res. 2015;21:4868-80 pubmed publisher |
Qiu B, Ackerman D, Sanchez D, Li B, Ochocki J, Grazioli A, et al. HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma. Cancer Discov. 2015;5:652-67 pubmed publisher |
Paster W, Bruger A, Katsch K, Grégoire C, Roncagalli R, Fu G, et al. A THEMIS:SHP1 complex promotes T-cell survival. EMBO J. 2015;34:393-409 pubmed publisher |
Suarez C, Deng X, Hu C. Targeting CREB inhibits radiation-induced neuroendocrine differentiation and increases radiation-induced cell death in prostate cancer cells. Am J Cancer Res. 2014;4:850-61 pubmed |
Shanzer M, Ricardo Lax I, Keshet R, Reuven N, Shaul Y. The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner. Oncogene. 2015;34:4190-8 pubmed publisher |
Siegle J, Basin A, Sastre Perona A, Yonekubo Y, Brown J, Sennett R, et al. SOX2 is a cancer-specific regulator of tumour initiating potential in cutaneous squamous cell carcinoma. Nat Commun. 2014;5:4511 pubmed publisher |
Mungamuri S, Wang S, Manfredi J, Gu W, Aaronson S. Ash2L enables P53-dependent apoptosis by favoring stable transcription pre-initiation complex formation on its pro-apoptotic target promoters. Oncogene. 2015;34:2461-70 pubmed publisher |
Zhang X, Ma D, Caruso M, Lewis M, Qi Y, Yi Z. Quantitative phosphoproteomics reveals novel phosphorylation events in insulin signaling regulated by protein phosphatase 1 regulatory subunit 12A. J Proteomics. 2014;109:63-75 pubmed publisher |
Tiemann U, Marthaler A, Adachi K, Wu G, Fischedick G, Araúzo Bravo M, et al. Counteracting activities of OCT4 and KLF4 during reprogramming to pluripotency. Stem Cell Reports. 2014;2:351-65 pubmed publisher |
Wu H, Whitfield T, Gordon J, Dobson J, Tai P, Van Wijnen A, et al. Genomic occupancy of Runx2 with global expression profiling identifies a novel dimension to control of osteoblastogenesis. Genome Biol. 2014;15:R52 pubmed publisher |
Willems L, Jacque N, Jacquel A, Neveux N, Maciel T, Lambert M, et al. Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia. Blood. 2013;122:3521-32 pubmed publisher |
Itou J, Matsumoto Y, Yoshikawa K, Toi M. Sal-like 4 (SALL4) suppresses CDH1 expression and maintains cell dispersion in basal-like breast cancer. FEBS Lett. 2013;587:3115-21 pubmed publisher |
Beronja S, Janki P, Heller E, Lien W, Keyes B, Oshimori N, et al. RNAi screens in mice identify physiological regulators of oncogenic growth. Nature. 2013;501:185-90 pubmed publisher |
Burns T, Dobromilskaya I, Murphy S, Gajula R, Thiyagarajan S, Chatley S, et al. Inhibition of TWIST1 leads to activation of oncogene-induced senescence in oncogene-driven non-small cell lung cancer. Mol Cancer Res. 2013;11:329-38 pubmed publisher |
He M, Jenkins P, Bennett V. Cysteine 70 of ankyrin-G is S-palmitoylated and is required for function of ankyrin-G in membrane domain assembly. J Biol Chem. 2012;287:43995-4005 pubmed publisher |
Kobayashi A, Okuda H, Xing F, Pandey P, Watabe M, Hirota S, et al. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J Exp Med. 2011;208:2641-55 pubmed publisher |
Wiederschain D, Wee S, Chen L, Loo A, Yang G, Huang A, et al. Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle. 2009;8:498-504 pubmed |
